Locus ceruleus morphometry in aging and schizophrenia

Acta Psychiatrica Scandinavica

Volumn 77, Issue 6, 1988, Pages 689-697

  Lohr, J B ^a   Jeste, D V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; locus cereleus; schizophrenia

Indexed keywords

NEUROMELANIN;

ADULT; AGE; AGING; CLINICAL ARTICLE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; LOBOTOMY; LOCUS CERULEUS; NERVE CELL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMAN; LOCUS COERULEUS; MALE; MIDDLE AGE; NEURONS; PSYCHOSURGERY; SCHIZOPHRENIA; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0023948638     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1988.tb05189.x     Document Type: Article

References (48)

1. Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse
2. Neuron numbers in locus coeruleus do not change with age in Fisher 344 rat
3. A quantitative histological study of neuronal loss from the locus coeruleus of ageing mice
4. Age‐related decline in the activity of noradrenergic neurons of the rat locus coeruleus
5. A quantitative study of the pigmented neurons in the nuclei locus coeruleus and sub‐coeruleus in man as related to aging
6. The effects of ageing on the pigmemed nerve cells of the human locus coeruleus and substantia nigra
7. On the origin and significance of neu‐romelanin
8. Biomathematical analysis of the neuronal loss in the aging human brain of both sexes, demonstrated in pigment preparations of the pars cerebellaris loci coerulei
9. Cell loss in the locus coeruleus in senile dementia of Alzheimer type
10. Neuropathology of the locus ceruleus: A semi‐quantitative study
11. Cholinergic and noradrenergic systems in aging, Alzheimer's disease and Down's syndrome
12. Norepine‐phrine in chronic paranoid schizophrenia: Above‐normal levels in limbic forebrain
13. Brain norepinephrine and dopamine in schizophrenia
14. Monoamine mechanisms in chronic schizophrenia: Post‐mortem neurochemical findings
15. Schizophrenia: Elevated cerebrospinal fluid norepinephrine
16. Noradrenergic overactivity in chronic schizophrenia: Evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations
17. Plasma norepinephrine and dopamine‐beta‐hydroxylase‐activity in schizophrenia
18. Interactions of antipsychotic drugs with norepinephrine and cerebellar neuronal circuitry: Implications for the psychobiology of psychosis
19. Acute haloperidol increases impulse activity of brain noradrenergic neurons
20. Chronic haloperidol inactivates brain noradrenergic neurons
21. Schizophrenia: A theory
22. Brain catecholamines in schizophrenia ‐ a good case for noradrenaline
23. Ex uno multi: Subtyping the schizophrenic syndrome
24. Designing a non‐neuroleptic antischizophrenic drug. The noradrenergic strategy
25. Neuromelanin, neuroleptics and schizophrenia: Hypothesis of an interaction between noradrenergic and dopaminergic system
26. A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker
27. Anatomical study of lobotomy.
28. Basal ganglia and limbic system pathology in schizophrenia
29. Methods for the counting of neurons.
30. Reduced Purkinje cell density in Huntington's disease
31. Cerebellar pathology in schizophrenia? A neuronometric study
32. Hippocampal pyramidal cells and aging in the human: A quantitative study of neuronal loss in sectors CA1 to CA4
33. Extension of multiple range tests to group means with unequal numbers of replications
34. Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia
35. Neuronal loss in normal aging and neuropsychiatric dementias.
36. Aging, regional cerebral blood flow, and neuropsychological functioning
37. Intellectual abilities.
38. Memory, aging, and dementia.
39. Motor performance.
40. Central noradrenergic regulation of cerebral blood flow and vascular permeability
41. Cerebral blood flow and oxygen consumption in the rat brain after lesions of the noradrenergic locus coeruleus system
42. Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesions
43. The human locus coeruleus in neurology and psychiatry
44. A morphometric study of the dopamine‐containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics
45. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats